Polyglutamine Repeat Length-Dependent Proteolysis of Huntingtin-Reference-Cited by-同舟云学术

Polyglutamine Repeat Length-Dependent Proteolysis of Huntingtin

Published:2002-10 Issue:1 Volume:11 Page:111-122
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Sun Banghua,Fan Wei,Balciunas Aldona,Cooper Jillian K.,Bitan Gal,Steavenson Shirley,Denis Paul E.,Young Yunjen,Adler Beverly,Daugherty Larry,Manoukian Raffi,Elliott Gary,Shen Wenyan,Talvenheimo Jane,Teplow David B.,Haniu Mitsuru,Haldankar Raj,Wypych Jette,Ross Christopher A.,Citron Martin,Richards William G.

Publisher

Elsevier BV

Subject

Neurology

Reference42 articles.

1. The nuclear pore complex: Mediator of translocation between nucleus and cytoplasm;Allen;J. Cell. Sci.,2000

2. The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size;Brinkman;Am. J. Hum. Genet.,1997

3. Transcriptional dysregulation in Huntington's disease;Cha;Trends Neurosci.,2000

4. Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture;Cooper;Hum. Mol. Genet.,1998

5. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1;Cummings;Nature Genet.,1998

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging Therapies for Huntington’s Disease – Focus on N-Terminal Huntingtin and Huntingtin Exon 1;Biologics: Targets and Therapy;2022-09

2. Deciphering the Structure and Formation of Amyloids in Neurodegenerative Diseases With Chemical Biology Tools;Frontiers in Chemistry;2022-05-12

3. Minimotifs dysfunction is pervasive in neurodegenerative disorders;Alzheimer's & Dementia: Translational Research & Clinical Interventions;2018-01

4. Proteolytic Cleavage of Polyglutamine Disease-Causing Proteins: Revisiting the Toxic Fragment Hypothesis;CURR PHARM DESIGN;2017

5. Impaired GAPDH ‐induced mitophagy contributes to the pathology of Huntington's disease;EMBO Molecular Medicine;2015-08-12